top of page
  • Amazon
  • Youtube
  • TikTok
  • Facebook
  • Instagram
Copy of kindle cover.jpg

DECODING GLP-1

An On The Pen Book

Interview With Noom CEO Jeff Cook
28:14

Interview With Noom CEO Jeff Cook

In this powerful interview, Noom CEO Geoff Cook opens up about his mission to bring down the cost of GLP-1 medications like Ozempic, Wegovy, and Zepbound—and why he believes compounding pharmacies could play a critical role in making these life-changing drugs more accessible. We dig into the failures of the U.S. healthcare system, how the Trump-era Most Favored Nation policy aimed to fight high drug prices, and why patients are still paying thousands out of pocket. If you care about affordable access to GLP-1s, compounded semaglutide, or the future of obesity care, this conversation is a must-watch.  WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP WHY I TRUST INTEGRATIVE PEPTIDES: 🇺🇸 Made in the USA 📋 CGMP Compliant (FDA oversight of their products) 🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA 📕 GET MY BOOK! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp https://amzn.to/4gAXrz4 SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com #ozempic #mounjaro #onthepen
Amazon Banned Our GLP-1 Book
18:08

Amazon Banned Our GLP-1 Book

GLPbook.com Amazon is silencing the voices of people living with obesity, and we need to fight back. The first thing you can do is share this article. This weekend, Amazon removed my book from their store, claiming it “disappoints customers.” But let’s be clear—this book isn’t just mine. It tells real stories from real people fighting obesity, stigma, and bias every single day. 🚨 This is not just about a book. This is about Amazon deciding whose stories deserve to be heard. 🚨 📢 Amazon is silencing us.📢 Amazon is erasing our voices.📢 Amazon is making it harder for people struggling with obesity to be understood. This book is not some medical “how-to” guide. It’s a collection of personal stories—mine and ten others from my community—documenting our struggles and triumphs. It’s about equipping people with the words they need when family, friends, and doctors dismiss their experiences. It’s about breaking the cycle of stigma. And yet, Amazon says that books like this are "disappointing." 📞 CALL & EMAIL AMAZON KDP Amazon’s system is mostly run by AI, and getting a real person on the phone is key. If we flood them with messages, we can push for an actual review. 📞 Call Amazon KDP Support: (888) 280-4331 📧 UPDATED INSTRUCTIONS FOR SENDING A MESSAGE Since Amazon no longer accepts direct emails, we need to use their official contact form to send messages. How to Submit a Message to KDP 1. Go to KDP Contact Form 2. Select Amazon Store & Conten 3. Choose “My Books Book Was Removed or Blocked” 4. In the message box, copy and paste the following: SAMPLE MESSAGE TO SUBMIT VIA KDP FORM 🚨 When you message KDP, make sure to include the book's ISBN: 979-8303353107 and demand a manual review. Here’s a sample email you can use: 📧 Sample Message to KDP Subject: Urgent Review Request – ISBN: 979-8303353107 Dear Kindle Direct Publishing, I am writing to formally request a manual review of the book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen (ISBN: 979-8303353107), which has been wrongfully removed from Amazon. This book provides real stories from people struggling with obesity and the stigma they face. It is not a generic guide but an essential resource helping families understand and support their loved ones. The book has nearly 500 sales and 50+ positive reviews, proving its value to readers. By removing this book, Amazon is silencing the voices of people living with obesity and taking away a much-needed resource for those seeking support. I urge you to reconsider this decision and reinstate the book. Thank you for your time, [Your Name] 📢 FLOOD SOCIAL MEDIA Amazon needs to hear us loud and clear. ✅ Repost this article. Share it everywhere. ✅ Tag @Amazon and @KindleDirectPublishing. Make them see us. ✅ Use the hashtags: #AmazonSilencesObesity and #OnThePen ✅ Post this to Instagram: Share this post The more noise we make, the harder it will be for them to ignore us. ✍️ LEAVE A REVIEW Astonishingly, It doesn't appear that it is too late to leave a review on Amazon! If you’ve read the book, please take one minute to submit a review here: Leave a review Positive reviews show how much this book matters and I would think it would make it harder for Amazon to justify keeping it off their platform. We Need to Act NOW This isn’t just about my book. This is about whether people living with obesity get to tell their own stories or if Big Tech gets to silence us. Amazon won’t reverse this decision unless we demand it. So let’s make them listen. 🔥 CALL. TAG. SHARE. REVIEW. EMAIL. 🔥 Let’s show Amazon that we are not going anywhere. #AmazonSilencesObesity #GLP1 #ObesityAwareness #OnThePen #WeightLoss #Advocacy
For Hers Super Bowl Commercial
05:02

For Hers Super Bowl Commercial

#Hims #superbowlcommercials #glp1 The Hims Super Bowl commercial is stirring up major controversy—but is the backlash justified? Let’s break it down together. The ad highlights America’s obesity epidemic, calling out a broken system that profits off keeping people sick. It pushes back against diet culture and promotes GLP-1 medications as an effective treatment. But does it get everything right? I take issue with the claim that "it’s not our bodies that are broken." Obesity is a chronic disease, not a moral failure, and medical treatment—including GLP-1 medications—is the missing puzzle piece for many. While Big Pharma often gets criticized, the real predatory industry is diet culture, not pharmaceutical companies that developed life-changing obesity treatments. That said, Hims is now facing what I believe is a media smear campaign, specifically targeting compounded GLP-1s. The truth? 503B compounding pharmacies are FDA-regulated and follow strict safety standards. If compounded medications were truly unsafe, we'd know by now. At the end of the day, the ad gets one thing 100% right: The system is broken. It prioritizes profits over patients, leaving millions without access to effective obesity treatment. 💬 What do you think? Drop your thoughts in the comments. 🔥 Advocating for accessibility to anti-obesity medications? Join the fight at OnThePen.com. 🔔 Like & Subscribe for more deep dives into GLP-1s, obesity treatment, and breaking health news! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4 📖Paperback: https://amzn.to/4gAXrz4 💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP USE CODE "OTP10" to save 10%. SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com
bottom of page